Johnson and Johnson pays $3.5 billion for DePuy
This article was originally published in Clinica
Johnson & Johnson is to acquire orthopaedics company DePuy in a deal worth around $3.5 billion. Roche, which holds 84% of DePuy, has agreed to sell its share of the company to J&J for $2.9 million. J&J will begin a cash tender offer for all outstanding shares of DePuy for $35 per share. The deal will result in an orthopaedics division for J&J with an annual turnover of around $1.4 billion.